Similar Articles
Paraneoplastic Rheumatic Disorders
Ömer Faruk ŞENDUR
DOI: 10.5606/tjr.2012.002
The Use of Complementary and Alternative Medicine in Turkish Patients with Rheumatic Diseases
Hasan ULUSOY, Tülün Kaya GÜÇER, Murat AKSU, Şule ARSLAN, Abdülkadir HABİBOĞLU, Gürkan AKGÖL, Ayhan BİLGİCİ, Ömer KURU, İlhan ÇETİN, Ayhan KAMANLI, Salih ÖZGÖÇMEN
DOI: 10.5606/tjr.2012.004
Diagnostic Role of Anti-Nuclear Antibodies in Rheumatic Diseases
Murat BİRTANE
DOI: 10.5606/tjr.2012.013
The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival
Veli SUNAR, Öztürk ATEŞ, Alma KORCALI ASLAN, Yusuf KARAKAŞ, Mustafa Kadri ALTUNDAĞ
DOI: 10.5606/ArchRheumatol.2019.6803
Nivolumab Induced Seronegative Arthritis in a Patient With Refractory Hodgkin’s Lymphoma
Seda ÇOLAK, Ahmet OMMA
DOI: 10.5606/ArchRheumatol.2019.7041
Nitroxidized-Albumin Advanced Glycation End Product and Rheumatoid Arthritis
Akhlas TARANNUM, Zarina ARIF, Khursheed ALAM, Shafeeque AHMAD, Moin UDDIN
DOI: 10.5606/ArchRheumatol.2019.7285
A Multicenter Analysis of Subjectivity of Indirect Immunofluorescence Test in Antinuclear Antibody Screening
Vildan TURAN FARAŞAT, Talat ECEMİŞ, Yavuz DOĞAN, Aslı Gamze ŞENER, Gülfem TEREK ECE, Pınar Erbay DÜNDAR, Tamer ŞANLIDAĞ
DOI: 10.5606/ArchRheumatol.2019.7310
Serum C-Reactive Protein/Albumin Ratio in Rheumatoid Arthritis and its Relationship With Disease Activity, Physical Function, and Quality of Life
İsmihan SUNAR, Şebnem ATAMAN
DOI: 10.46497/ArchRheumatol.2020.7456
Outcomes and Risk Factors of Systolic Pulmonary Artery Pressure Progression in Patients with Systemic Rheumatic Diseases: Follow-up Results from a Korean Registry
Mi Ryoung SEO, Jina YEO, Hee Jung RYU, Hyo-jin CHOI, Kwang-pil KO, Han Joo BAEK
DOI: 10.46497/ArchRheumatol.2020.7812